Sharanya Sivanand
@ssivanand.bsky.social
postdoc at @mvhlab.bsky.social
New role for ACAD10/11… Check out the new paper from @edreesrashan.bsky.social and team out in @natsmb.nature.com See below for details 👇
AND IT'S DONE! A 🧵 on our recent article now out in @natsmb.nature.com! Co-led with @abbybartlett.bsky.social, Pagliarini Lab, @judisimcox.bsky.social, we find ACAD10/11 are NOT like other acyl-CoA dehydrogenases and instead catabolize atypical lipids called 4-hydroxy acids 🤯 doi.org/10.1038/s415...
ACAD10 and ACAD11 enable mammalian 4-hydroxy acid lipid catabolism - Nature Structural & Molecular Biology
Rashan, Bartlett and colleagues show that mammalian 4-hydroxy fatty acids are primarily catabolized by ACAD10 and ACAD11 (atypical mitochondrial and peroxisomal acyl-CoA dehydrogenases, respectively) ...
doi.org
June 23, 2025 at 12:03 AM
New role for ACAD10/11… Check out the new paper from @edreesrashan.bsky.social and team out in @natsmb.nature.com See below for details 👇
Reposted by Sharanya Sivanand
Patients and patient advocates: consider visiting your congress representatives offices to advocate for funding for research.
The development of new treatments and diagnoses require funding of basic and translational research in academic laboratories.
The development of new treatments and diagnoses require funding of basic and translational research in academic laboratories.
November 21, 2024 at 1:17 PM
Patients and patient advocates: consider visiting your congress representatives offices to advocate for funding for research.
The development of new treatments and diagnoses require funding of basic and translational research in academic laboratories.
The development of new treatments and diagnoses require funding of basic and translational research in academic laboratories.
Reposted by Sharanya Sivanand
November 15, 2024 at 5:50 AM